O'Toole C, Helmstein K, Perlmann P, Moberger G
Int J Cancer. 1975 Sep 15;16(3):413-26. doi: 10.1002/ijc.2910160308.
The effects of hydrostatic pressure therapy on in vitro cellular cytotoxicity responses have been studied in 19 patients with transitional cell carcinoma of the bladder (TCC). Cytotoxicity was quantitated against allogeneic targets in a microplate assay or by 51chromium isotope release. Two types of reactivity were detected, the most common being a differential cytotoxicity for targets derived from TCC, in either short-term or long-term tissue culture. This reaction is operationally termed "tumor-specific". Less frequently, a general cytotoxicity for targets of diverse histogenic origins was observed. For the present, this is termed "non-specific". Nine patients were tested before pressure therapy and of these only two gave a specific reaction and one a non-specific reaction, while six were non-reactive. Eighteen patients were tested at varying intervals after treatment and of these 11 gave a specific reaction and one a non-specific effect, while six were non-reactive. Three individuals who were non-reactive prior to therapy had a specific reaction post therapy. Two who reacted specifically before therapy became non-reactive post therapy. The results of serial in vitro testing for cytotoxicity are presented with individual case histories, tumor staging and grading and the clinical outcome of hydrostatic pressure therapy.
在19例膀胱移行细胞癌(TCC)患者中研究了静水压力疗法对体外细胞毒性反应的影响。通过微孔板试验或51铬同位素释放对同种异体靶标的细胞毒性进行定量。检测到两种反应类型,最常见的是对短期或长期组织培养中源自TCC的靶标的差异细胞毒性。这种反应在操作上被称为“肿瘤特异性”。较少见的是,观察到对多种组织起源的靶标的一般细胞毒性。目前,这被称为“非特异性”。9例患者在压力疗法前接受检测,其中只有2例出现特异性反应,1例出现非特异性反应,6例无反应。18例患者在治疗后的不同时间间隔接受检测,其中11例出现特异性反应,1例出现非特异性反应,6例无反应。3例治疗前无反应的个体在治疗后出现特异性反应。2例治疗前有特异性反应的个体在治疗后无反应。本文呈现了细胞毒性系列体外检测结果,并结合个体病例史、肿瘤分期和分级以及静水压力疗法的临床结果。